[Cytochrome-P-4502C19 gene polymorphism and Helicobacter pylori infection treatment].
Maev
I V
IV
Oganesian
T S
TS
Momynaliev
K T
KT
Kucheriavyĭ
Iu A
IuA
Belyĭ
P A
PA
D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000502:physiology; D065731:Cytochrome P-450 CYP2C19; D005787:Gene Frequency; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000201:enzymology; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008657:Metabolic Clearance Rate; D020641:Polymorphism, Single Nucleotide; D054328:Proton Pump Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19